DE60335202D1 - Chaperonin-10-immunosuppression - Google Patents

Chaperonin-10-immunosuppression

Info

Publication number
DE60335202D1
DE60335202D1 DE60335202T DE60335202T DE60335202D1 DE 60335202 D1 DE60335202 D1 DE 60335202D1 DE 60335202 T DE60335202 T DE 60335202T DE 60335202 T DE60335202 T DE 60335202T DE 60335202 D1 DE60335202 D1 DE 60335202D1
Authority
DE
Germany
Prior art keywords
donor
recipient animal
cpn10
administration
host disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60335202T
Other languages
German (de)
English (en)
Inventor
Geoffrey R Hill
Tatjana Banovic
Halle Coorparoo Morton
Alice Christina Cavanagh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CBio Ltd
Original Assignee
CBio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CBio Ltd filed Critical CBio Ltd
Application granted granted Critical
Publication of DE60335202D1 publication Critical patent/DE60335202D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60335202T 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression Expired - Lifetime DE60335202D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (1)

Publication Number Publication Date
DE60335202D1 true DE60335202D1 (en) 2011-01-13

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60335202T Expired - Lifetime DE60335202D1 (en) 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression

Country Status (16)

Country Link
US (3) US7618935B2 (enExample)
EP (3) EP2255824B1 (enExample)
JP (2) JP4716731B2 (enExample)
KR (1) KR101088740B1 (enExample)
CN (1) CN100525832C (enExample)
AT (1) ATE489963T1 (enExample)
AU (1) AU2002952492A0 (enExample)
CA (1) CA2505141C (enExample)
CY (1) CY1110972T1 (enExample)
DE (1) DE60335202D1 (enExample)
DK (1) DK1569679T3 (enExample)
ES (1) ES2351993T3 (enExample)
NZ (1) NZ540433A (enExample)
PT (1) PT1569679E (enExample)
SI (1) SI1569679T1 (enExample)
WO (1) WO2004041300A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007517808A (ja) 2004-01-16 2007-07-05 キュビオ リミテッド Ｔｏｌｌ様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン１０調節
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
EP1906989A4 (en) 2005-07-11 2009-08-19 Cbio Ltd IMMUNOMODULATION INDUCED BY CHAPERONIN 10
EP2463307A1 (en) 2005-08-31 2012-06-13 CBIO Limited Modified chaperonin 10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CA2626692A1 (en) * 2005-10-20 2007-04-26 Cbio Limited Treatment of hypersensitivity
MX2008011167A (es) 2006-03-02 2008-11-12 Cbio Ltd Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos.
CA2720617A1 (en) * 2008-04-11 2009-10-15 Cbio Limited Modified cpn10 and prr signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
US10842913B2 (en) 2012-12-10 2020-11-24 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
RU2677637C2 (ru) 2013-08-13 2019-01-18 Эластаджен Пти Лтд Регенерация поврежденной ткани

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
WO1995015338A1 (en) 1993-11-30 1995-06-08 The University Of Queensland Chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
EP1218030A4 (en) 1999-09-10 2004-09-15 Univ Fordham METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRANSPLANT REJECTION BY USING HEAT SHOCK PROTEINS
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
CN1735428A (zh) 2006-02-15
US20120082690A1 (en) 2012-04-05
EP1569679A4 (en) 2008-02-27
EP2255824B1 (en) 2014-07-23
EP1569679B1 (en) 2010-12-01
DK1569679T3 (da) 2011-01-10
JP4716731B2 (ja) 2011-07-06
AU2002952492A0 (en) 2002-11-21
EP2255824A1 (en) 2010-12-01
ES2351993T3 (es) 2011-02-14
US7618935B2 (en) 2009-11-17
SI1569679T1 (sl) 2011-01-31
KR101088740B1 (ko) 2011-12-01
CA2505141A1 (en) 2004-05-21
WO2004041300A1 (en) 2004-05-21
PT1569679E (pt) 2010-12-14
ATE489963T1 (de) 2010-12-15
EP2818179A1 (en) 2014-12-31
CY1110972T1 (el) 2015-06-11
US8067361B2 (en) 2011-11-29
US20060198834A1 (en) 2006-09-07
NZ540433A (en) 2008-03-28
KR20050086428A (ko) 2005-08-30
US20100099605A1 (en) 2010-04-22
CN100525832C (zh) 2009-08-12
CA2505141C (en) 2012-07-17
JP2006508099A (ja) 2006-03-09
EP1569679A1 (en) 2005-09-07
JP2011088920A (ja) 2011-05-06

Similar Documents

Publication Publication Date Title
CY1110972T1 (el) Ανοσοκαταστολη με σαπερονινη 10
WO2005051232A3 (en) Soft tissue implants and anti-scarring agents
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
WO2004028243A3 (en) Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
EP1487431A4 (en) PREVENTING AND / OR TREATING CARDIOVASCULAR DISEASE AND / OR RELATED CARDIAC INSUFFICIENCY
WO2002022184A3 (en) Bioengineered flat sheet graft prosthesis and its use
IS4409A (is) Notkun á kítósan og fjölsykru í tengslum við endurmyndun á hörðum vef, ásamt ígræðlingi
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
WO2004087006A3 (en) Implant delivery technologies
BR0203650A (pt) Estentor de auto-articulação
YU97402A (sh) Koštana (transkutalna) proteza
WO2007076508A3 (en) Implantable graft material
WO1999062425A3 (en) Bioengineered vascular graft prostheses
EP1688425A3 (en) Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
EP1676574A3 (en) Methods for promoting survival of transplanted tissues and cells
WO2004039248A3 (en) Repairing or replacing tissues or organs
CA2286655A1 (en) Tissue decellularization
AU2003222513A1 (en) Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
WO2001068828A3 (en) Compositions and methods for regulated protein expression in gut
PL376302A1 (en) New use of dextran sulfate
WO2004091436A3 (en) Methods and compositions for treating ocular disease
WO2005041877A3 (en) Method of inhibiting rejection following organ transplantation
DE60213766D1 (de) Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion
IL148980A0 (en) An antibody to human tissue factor and experimental animals having inserted cells with the gene encoding human tissue factor